3 Reasons to Buy This Beaten-Down Stock on the Dip

MercadoLibre shares have fallen 22% over the past 12 months amid profit/margin pressure, but the firm is seeing signs of recovery after deliberate investment: Q1 revenue rose 49% to $8.8B while operating income fell 20% to $611M and operating margin slipped 600 bps to 6.9% (EPS $8.23 vs prior $9.74; below estimates). Management-related headwinds from initiatives like lowering free-shipping thresholds and expanding its credit card business may weigh near term, but GMV acceleration in Brazil and a 63% YoY jump in advertising revenue suggest improving long-run profitability. The stock is up 13% over the past month and the article argues the market premium (36x forward earnings vs 25.3x for consumer discretionary) is justified by multiple growth avenues and competitive moat.

Analysis

The setup is classic “growth now, margin later,” but the market usually underwrites that story only if unit economics stabilize within a couple of quarters. MELI’s current issue is not demand fatigue; it is that incremental revenue is being bought with too much operating leverage and credit risk up front, which can keep consensus EPS revisions sliding even if top-line acceleration persists. That makes the stock vulnerable to another de-rating if the next print shows revenue still strong but operating margin failing to trough.

Second-order, the real competitive risk is not Shopee stealing the whole market; it is MELI forcing rivals to spend harder to match logistics and financing breadth. That can rationally support MELI’s moat, but it also raises industry CAC and subsidy intensity, which may compress returns for SE before it meaningfully hurts MELI share. Over 6-18 months, the more important upside is that ads and payments can shift mix toward higher-margin take rates; if those lines continue compounding, the market will eventually pay a higher quality multiple rather than a pure GMV multiple.

Contrarian view: the consensus may be too anchored on reported margin weakness and too dismissive of optionality in credit and ads. But the move may still be underdone on the downside if investors realize that “investing for the future” can persist longer than expected in Latin America, where regulatory, credit, and logistics complexity delay operating leverage. The key falsifier is a second straight quarter of strong GMV/revenue without margin inflection; that would argue the current 36x forward multiple is too rich for a business still in spending mode.

Key Decisions for Investors

• Avoid chasing MELI into strength; prefer to wait for the next earnings print and look for a better entry only if operating margin stabilizes or FCF conversion improves. Risk/reward is poor if the stock rerates on revenue alone while EPS keeps missing.
• Pair trade: long MELI / short SE only if you want to express a moat-vs-competition view, but size modestly and use a 2-3 month horizon. The thesis works only if MELI’s margin trough is visible before SE’s subsidy burn translates into slower growth; otherwise both legs can work against you.
• Short-term hedge: buy MELI downside via puts into the next earnings window if implied volatility is not already elevated. The catalyst is another guide-down on margin, not revenue, and that is the cleaner way to express risk than outright shorting a structurally strong franchise.
• For longer-duration investors, consider adding on weakness only after confirming ad growth and credit loss trends, since those are the mix-shift levers that can re-rate the multiple over 6-18 months. Without that proof, treat MELI as a watchlist name rather than a core long.
• Use a relative-value lens versus consumer discretionary and EM internet proxies: MELI can deserve a premium, but not if earnings revisions keep drifting lower. Falsifier for a bullish re-entry is a quarter where revenue remains >40% and margins stop deteriorating.